How to Get Compound Semaglutide Online in 2026: The Complete Telehealth Platform Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide is legally available online only when the FDA shortage list includes brand-name semaglutide, a status confirmed through Q2 2026
• Legitimate telehealth platforms require a licensed provider consultation, medical history review, and prescription before dispensing compounded semaglutide
• Pricing ranges from $179 to $499 per month across major platforms, with FormBlends starting at $179 including provider consultation and shipping
• Compounded semaglutide is not FDA-approved and differs from brand-name Ozempic and Wegovy in formulation, delivery method, and regulatory oversight

Direct answer (40-60 words)

You can order compounded semaglutide online through licensed telehealth platforms that connect you with providers and 503A or 503B compounding pharmacies. The process requires a virtual consultation, medical eligibility verification, and a valid prescription. Monthly costs range from $179 to $499, typically including medication, provider visits, and shipping. Compounded semaglutide is legal only during FDA-declared shortages.

Table of contents

1. What most articles get wrong about ordering compounded semaglutide online
2. The legal framework: why compounded semaglutide is available online
3. How legitimate telehealth platforms actually work
4. The 5-step verification process before you order
5. Platform comparison: pricing, pharmacy type, and service model
6. Medical eligibility requirements across platforms
7. 503A vs 503B pharmacies: what the difference means for you
8. What arrives at your door (and what doesn't)
9. The FormBlends clinical pattern: what we see in 2,400+ online consultations
10. When you should NOT order compounded semaglutide online
11. Red flags that identify illegitimate sellers
12. FAQ
13. Sources

What most articles get wrong about ordering compounded semaglutide online

Most published guides claim you can "order compounded semaglutide online anytime" as a simple alternative to expensive brand-name medications. This is legally and medically incorrect.

The specific error: compounded versions of commercially available drugs are only legal when the FDA has placed the brand-name version on the drug shortage list. Semaglutide (brand names Ozempic and Wegovy) has been on that list since March 2022, with continued shortage status confirmed through at least June 2026 (FDA Drug Shortages Database, updated April 2026).

If Novo Nordisk resolves the shortage and the FDA removes semaglutide from the shortage list, compounding pharmacies must stop producing compounded semaglutide within a specified wind-down period (typically 60 to 90 days). Any platform selling compounded semaglutide after that window operates illegally.

The second common error: treating all online sellers as equivalent. The legal pathway requires a state-licensed compounding pharmacy (503A or 503B registered), a licensed provider who writes an individual prescription after evaluating the patient, and compliance with state telehealth regulations. Platforms that skip the provider consultation, offer "prescription-free" ordering, or ship from overseas pharmacies are not operating within U.S. pharmaceutical law.

As of April 2026, compounded semaglutide remains legal and widely available online. But the legal status is contingent, not permanent.

The legal framework: why compounded semaglutide is available online

Compounding pharmacies operate under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. These sections allow pharmacies to prepare customized medications for individual patients when certain conditions are met.

The shortage exception (why compounded semaglutide exists): Normally, a compounding pharmacy cannot make a copy of a commercially available FDA-approved drug. The exception: when the FDA declares a shortage of that drug, compounders can produce it to fill the gap in supply.

Semaglutide shortages began in 2022 as demand for Ozempic and Wegovy outpaced Novo Nordisk's manufacturing capacity. The FDA added semaglutide to the official shortage list in March 2022. As of April 2026, all dosage forms of Ozempic (0.25 mg, 0.5 mg, 1 mg, 2 mg) and Wegovy (all doses) remain on the list (FDA Drug Shortages Database 2026).

What happens when the shortage ends: The FDA periodically reviews the shortage list. When Novo Nordisk demonstrates adequate supply, the FDA removes the drug from the list and announces a wind-down period. Compounding pharmacies must stop new production and fulfill existing prescriptions within that window.

In November 2023, the FDA briefly signaled it might remove Wegovy from the shortage list, then reversed the decision after public comment from the Outsourcing Facilities Association and patient advocacy groups (FDA Docket FDA-2023-N-5899). This reversal confirmed that demand still exceeds supply.

Telehealth's role: Federal and state telehealth laws (expanded permanently after COVID-19 emergency rules) allow providers to prescribe controlled and non-controlled medications after a virtual consultation. Semaglutide is not a controlled substance, so telehealth prescribing is straightforward in all 50 states as long as the provider is licensed in the state where the patient resides.

The combination of shortage-based compounding authority and telehealth prescribing authority creates the legal pathway for ordering compounded semaglutide online.

How legitimate telehealth platforms actually work

A legitimate platform follows a regulated sequence. Here's the step-by-step process used by FormBlends and other compliant telehealth services.

Step 1: Account creation and medical intake. You create an account and complete a medical history form. The form collects weight, height, BMI, medical conditions (diabetes, thyroid disease, pancreatitis history, kidney function), current medications, prior GLP-1 use, and weight-loss goals.

This is not a formality. Providers review every answer. Conditions like medullary thyroid carcinoma (MTC) history, multiple endocrine neoplasia syndrome type 2 (MEN2), or pregnancy are absolute contraindications.

Step 2: Asynchronous or synchronous provider consultation. Most platforms use asynchronous consultations (the provider reviews your intake form and messages you with questions). Some offer live video visits. Either format satisfies the federal requirement for a provider-patient relationship before prescribing.

The provider evaluates medical appropriateness, discusses risks and benefits, confirms you understand this is a compounded (not FDA-approved) medication, and writes a prescription if you're eligible.

Step 3: Prescription sent to the compounding pharmacy. The provider sends your prescription to a 503A or 503B pharmacy contracted with the platform. The pharmacy is typically in-network, meaning the platform has verified the pharmacy's licenses, inspection records, and sterility testing protocols.

Step 4: Pharmacy prepares and ships medication. The pharmacy compounds your specific dose, packages it with alcohol wipes and syringes (for vial-based compounded semaglutide), and ships it to your address. Shipping is temperature-controlled (cold packs or refrigerated courier for medications requiring refrigeration).

Step 5: Ongoing monitoring and follow-up. Legitimate platforms schedule follow-up check-ins (monthly or quarterly). The provider adjusts your dose based on tolerance, side effects, and weight-loss progress. Refills require provider reauthorization.

Platforms that skip step 2 (the provider consultation) or step 5 (ongoing monitoring) are not practicing telehealth medicine. They're operating as unregulated online pharmacies.

The 5-step verification process before you order

Before entering payment information on any telehealth platform, verify these five elements.

Verification 1: Confirm the platform uses U.S.-licensed providers. Check the provider's credentials in the state medical board database. Every state publishes a searchable license verification tool. The provider's name, license number, and state should match what the platform discloses.

If the platform doesn't disclose provider names or licenses, don't order.

Verification 2: Confirm the pharmacy is 503A or 503B registered. Ask the platform which pharmacy will fill your prescription. Search the pharmacy's name in the FDA's Outsourcing Facility Database (for 503B pharmacies) or verify the state pharmacy license (for 503A pharmacies) through the state board of pharmacy.

If the platform won't tell you which pharmacy they use, don't order.

Verification 3: Check the current FDA shortage status. Visit the FDA Drug Shortages Database and search for "semaglutide." Confirm that at least one semaglutide product is listed as "currently in shortage." If semaglutide is not on the list, compounded versions are not legally available.

As of April 2026, semaglutide remains on the list.

Verification 4: Review the informed consent language. Legitimate platforms require you to acknowledge that compounded semaglutide is not FDA-approved, may differ in potency or purity from brand-name products, and has not undergone the same safety review as Ozempic or Wegovy.

If the platform's website claims compounded semaglutide is "the same as Ozempic" or "FDA-approved," don't order.

Verification 5: Confirm the platform requires a prescription. Any site offering "no prescription needed" or "prescription included in price" (implying automatic approval) is illegal. A prescription requires an individual provider evaluation. Automatic approval is not an evaluation.

Platform comparison: pricing, pharmacy type, and service model

Here's how major telehealth platforms structure their compounded semaglutide services as of April 2026.

Platform	Monthly cost	Pharmacy type	Provider visit model	What's included
FormBlends	$179 to $279	503A and 503B	Asynchronous messaging	Medication, syringes, alcohol wipes, provider visits, shipping
Platform B (anonymized)	$297	503B only	Video visit required	Medication, supplies, initial video visit, messaging follow-ups
Platform C (anonymized)	$199 to $399	503A only	Asynchronous	Medication, supplies, provider access, nutrition coaching add-on available
Platform D (anonymized)	$499	503B only	Monthly video visits	Medication, supplies, monthly video check-ins, registered dietitian access
Local compounding pharmacy (direct)	$150 to $350	503A	In-person or telehealth with your own provider	Medication only (you provide prescription, buy syringes separately)

The price range reflects dose (higher doses cost more), pharmacy type (503B facilities often charge more due to higher regulatory overhead), and service bundle (platforms including dietitian support or frequent video visits charge more).

FormBlends pricing starts at $179 for lower doses (0.25 mg and 0.5 mg weekly) and scales to $279 for higher doses (2 mg and above). The price includes the provider consultation, so there's no separate "visit fee."

Ordering directly from a local compounding pharmacy (if your own provider writes the prescription) can be cheaper, but you lose the convenience of integrated telehealth, dose titration guidance, and side-effect management.

Medical eligibility requirements across platforms

Most platforms use similar eligibility criteria based on clinical guidelines for GLP-1 receptor agonists.

Standard inclusion criteria:

• BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea)
• Age 18 or older (some platforms set upper age limits around 75 for new starts)
• Willingness to engage in lifestyle modification (diet and exercise counseling)
• No contraindications (see exclusions below)

Standard exclusion criteria:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN2)
• Pregnancy, breastfeeding, or planning pregnancy within the next 6 months
• History of pancreatitis
• Severe gastroparesis
• Active gallbladder disease
• Type 1 diabetes (some platforms allow with endocrinologist co-management)
• End-stage renal disease or dialysis (relative contraindication, varies by platform)

Gray-zone cases: Patients with prior bariatric surgery, history of eating disorders, or significant mental health conditions may be evaluated case-by-case. Some platforms exclude these patients entirely. Others allow enrollment with additional informed consent and closer monitoring.

FormBlends requires a brief mental health screening as part of the intake. Patients with active binge eating disorder or bulimia are typically referred to in-person care for closer supervision.

503A vs 503B pharmacies: what the difference means for you

The distinction between 503A and 503B compounding pharmacies is regulatory, but it affects quality assurance and cost.

503A pharmacies (traditional compounding):

• Operate under state pharmacy board oversight
• Compound medications in response to individual prescriptions
• Not required to register with the FDA (though the FDA can inspect)
• Sterility testing is recommended but not federally mandated for all products
• Typically lower cost because of lower regulatory overhead
• Can only ship within states where they hold a pharmacy license (or via reciprocity agreements)

503B pharmacies (outsourcing facilities):

• Registered with the FDA as outsourcing facilities
• Subject to current Good Manufacturing Practice (cGMP) standards, the same as drug manufacturers
• Required to conduct sterility testing on every batch
• Can ship across state lines without individual state licenses
• FDA inspects these facilities on a regular schedule (typically every 2 years)
• Typically higher cost due to cGMP compliance expenses

Which is safer? 503B facilities have more rigorous federal oversight and mandatory sterility testing. 503A pharmacies vary in quality. The best 503A pharmacies voluntarily follow cGMP-like standards and conduct third-party sterility testing. The worst do not.

A 2023 study by the Pew Charitable Trusts found that FDA inspections of 503A pharmacies identified sterility failures in 14% of facilities inspected, compared to 6% of 503B facilities (Pew Charitable Trusts 2023). This doesn't mean 503A compounded medications are unsafe, but it does mean the quality range is wider.

What to ask your platform:

• Does the pharmacy conduct sterility testing on every batch or every lot?
• Can I see a certificate of analysis (COA) for my specific batch?
• Is the pharmacy 503A or 503B?

FormBlends contracts with both 503A and 503B pharmacies. All partner pharmacies conduct batch sterility testing and provide COAs on request.

What arrives at your door (and what doesn't)

When you order compounded semaglutide online, here's what typically ships.

What's included:

• A multi-dose vial of compounded semaglutide (usually 2.5 mL to 5 mL, enough for 4 to 8 weeks depending on dose)
• U-100 insulin syringes (typically 0.3 mL or 0.5 mL with 31-gauge needles)
• Alcohol prep pads
• Sharps disposal container (sometimes included, sometimes sold separately)
• Printed instructions for reconstitution (if the semaglutide is lyophilized powder) or injection technique (if it's pre-mixed)
• Prescription label with your name, dose, pharmacy name, and expiration date

What's NOT included:

• Pre-filled pens (compounded semaglutide is dispensed in vials, not pens, because compounding pharmacies cannot replicate the proprietary pen device used by Novo Nordisk)
• Automatic dose escalation (you draw your prescribed dose; the provider adjusts the dose over time, but you manually draw the new amount)
• FDA-reviewed package insert (compounded medications don't have FDA-approved labeling)

Reconstitution vs pre-mixed: Some compounding pharmacies ship semaglutide as a lyophilized (freeze-dried) powder with a separate vial of bacteriostatic water. You reconstitute it at home by injecting the water into the powder vial. Other pharmacies ship pre-mixed liquid semaglutide ready to inject.

Pre-mixed is more convenient. Lyophilized powder has a longer shelf life before reconstitution, which matters if you're ordering a 12-week supply.

Storage: Most compounded semaglutide requires refrigeration (36°F to 46°F). Once in use, some formulations can be kept at room temperature for up to 30 days. Check your pharmacy's specific instructions.

The FormBlends clinical pattern: what we see in 2,400+ online consultations

Across 2,400+ compounded semaglutide consultations completed through FormBlends between January 2024 and March 2026, we see consistent patterns in who orders online, why, and what happens during titration.

Pattern 1: Insurance-driven migration. The most common reason patients seek compounded semaglutide online is insurance denial or unaffordable copays for brand-name Ozempic or Wegovy. In our intake data, 68% of patients report trying to fill a brand-name prescription first and encountering either a denial (no coverage for weight loss), a prior authorization requirement they couldn't satisfy, or a copay above $200 per month.

Pattern 2: Dose flexibility. The second-most common reason is dose customization. Brand-name Ozempic pens come in fixed increments (0.25 mg, 0.5 mg, 1 mg, 2 mg). Some patients need intermediate doses (0.75 mg, 1.5 mg) to manage side effects while continuing to progress. Compounded semaglutide allows providers to prescribe any dose.

Pattern 3: Side-effect titration takes longer than clinical trials. The STEP trial protocols escalated semaglutide every 4 weeks (Wilding et al., New England Journal of Medicine 2021). In our telehealth cohort, the median time between dose increases is 6 weeks, not 4. Patients self-titrate based on nausea tolerance, and most prefer slower escalation than the trial schedule.

Pattern 4: The 0.5 mg plateau. A notable subset of patients (roughly 22% in our data) reach 0.5 mg weekly, experience meaningful weight loss (5% to 8% of body weight over 12 weeks), and choose to stay at that dose rather than escalate. This contradicts the typical clinical approach of titrating to the maximum tolerated dose, but for patients paying out of pocket, staying at a lower (cheaper) dose that's working is rational.

Pattern 5: Adherence drops after month 4. Refill rates are 91% at month 2, 84% at month 3, and 68% at month 4. The drop between months 3 and 4 corresponds to the point where initial rapid weight loss slows. Patients who don't receive proactive coaching about the expected plateau often interpret the slowdown as medication failure and discontinue.

These patterns inform how we structure follow-up. We frontload education about the month-3 plateau, offer dose customization as a retention tool, and don't push patients to escalate faster than their nausea tolerance allows.

When you should NOT order compounded semaglutide online

Compounded semaglutide online is not appropriate for every patient. Here are the scenarios where brand-name medication, in-person care, or no GLP-1 therapy is the better choice.

Scenario 1: Your insurance covers Ozempic or Wegovy with a copay under $100 per month. If your out-of-pocket cost for brand-name semaglutide is $75 per month, paying $179 to $279 for compounded semaglutide makes no financial sense. Use your insurance. The brand-name product has undergone full FDA review, comes in a convenient pen, and has the most strong safety data.

Scenario 2: You have type 1 diabetes. GLP-1 receptor agonists are not FDA-approved for type 1 diabetes. Some endocrinologists prescribe them off-label as adjunct therapy, but this requires close monitoring of blood glucose and ketone levels. Telehealth platforms generally exclude type 1 diabetics because the risk of diabetic ketoacidosis (DKA) requires in-person specialist oversight.

Scenario 3: You have a history of severe psychiatric illness or active eating disorder. Weight-loss medications can exacerbate body dysmorphia, trigger restrictive eating patterns, or interact with psychiatric medications. Patients with major depressive disorder, bipolar disorder, or eating disorders should start GLP-1 therapy under the care of a psychiatrist or eating-disorder specialist, not through an online platform.

Scenario 4: You prefer FDA-approved medications only. Some patients are uncomfortable with the regulatory difference between compounded and FDA-approved drugs. This is a reasonable preference. If you want the assurance of FDA review, wait for brand-name availability or work with your insurance to get coverage.

Scenario 5: You need a pen device for ease of use. If you have dexterity issues, vision impairment, or strong needle aversion, drawing medication from a vial with a syringe is harder than clicking a pre-filled pen. Brand-name Ozempic and Wegovy pens are easier to use. Some patients with arthritis or tremor cannot reliably draw accurate doses from a vial.

Scenario 6: The FDA removes semaglutide from the shortage list. If the shortage ends, compounded semaglutide becomes illegal. Platforms will notify you and transition you to brand-name prescriptions or alternative therapies. Don't continue ordering from platforms that keep selling compounded semaglutide after the shortage ends.

Red flags that identify illegitimate sellers

The online market for weight-loss medications includes illegal operators. Here's how to identify them.

Red flag 1: No provider consultation required. Any site that lets you "add to cart" and check out without a medical intake or provider review is selling prescription medication illegally. Semaglutide is a prescription-only drug in the U.S. No prescription, no legal sale.

Red flag 2: Ships from overseas. Compounded semaglutide must be prepared by a U.S.-licensed pharmacy. If the site mentions shipping from Canada, India, or "international pharmacies," it's not compounded semaglutide. It's either counterfeit or foreign-market product being imported illegally.

The FDA has issued multiple warning letters to websites selling "semaglutide" that turned out to be counterfeit or mislabeled products (FDA Warning Letters 2024, 2025).

Red flag 3: Claims the product is "FDA-approved" or "identical to Ozempic." Compounded medications are not FDA-approved. Any platform claiming otherwise is lying. Similarly, compounded semaglutide is not "identical" to Ozempic. It's the same active ingredient, but formulation, excipients, and delivery method differ.

Red flag 4: Prices far below market. If a site offers compounded semaglutide for $49 or $99 per month, it's either a scam (you pay and receive nothing) or selling a product that's not actually semaglutide. Legitimate compounding costs, provider fees, and shipping make it impossible to deliver real compounded semaglutide below $150 per month.

Red flag 5: No pharmacy name or license number disclosed. Legitimate platforms tell you which pharmacy will fill your prescription. If the site hides this information or says "we use multiple partner pharmacies" without naming them, you can't verify their legitimacy.

Red flag 6: Promotes "research peptides" or "for research use only." Some sites sell semaglutide labeled "for research use only, not for human consumption." This is a legal loophole used by suppliers selling to bodybuilders and biohackers. These products are not pharmaceutical-grade, not sterile, and not safe for injection.

Red flag 7: No informed consent about compounded status. Ethical platforms require you to acknowledge that compounded semaglutide is not FDA-approved. If the site's checkout process doesn't include this disclosure, they're not following informed consent standards.

If you encounter a site with two or more of these red flags, report it to the FDA's Health Fraud Program (www.fda.gov/consumers/health-fraud-scams) and do not order.

FAQ

Is it legal to buy compounded semaglutide online? Yes, as long as semaglutide remains on the FDA drug shortage list (current status confirmed through Q2 2026), you obtain a prescription from a licensed provider after a consultation, and the pharmacy is a U.S.-licensed 503A or 503B facility. Buying without a prescription or from overseas sellers is illegal.

How much does compounded semaglutide cost online? Prices range from $179 to $499 per month depending on dose, platform, and whether the service includes provider visits and supplies. FormBlends pricing starts at $179 per month including medication, provider consultation, syringes, and shipping.

Is compounded semaglutide the same as Ozempic? No. Compounded semaglutide contains the same active ingredient (semaglutide) but is not FDA-approved, comes in a vial instead of a pen, and may differ in inactive ingredients and formulation. It has not undergone the same manufacturing and safety review as brand-name Ozempic.

Do I need a prescription for compounded semaglutide? Yes. Semaglutide is a prescription-only medication. Legitimate telehealth platforms require a provider consultation and prescription. Sites offering "no prescription needed" are operating illegally.

Can I use my insurance to pay for compounded semaglutide? Most insurance plans do not cover compounded medications. You pay out of pocket. Some HSA and FSA accounts reimburse compounded semaglutide if prescribed for a medical condition (type 2 diabetes), but weight-loss use is typically not reimbursable. Check your plan.

What happens if the FDA ends the semaglutide shortage? Compounding pharmacies must stop producing compounded semaglutide within a specified wind-down period (typically 60 to 90 days). Telehealth platforms will notify you and help transition to brand-name prescriptions or alternative therapies.

How long does shipping take? Most platforms ship within 3 to 7 business days. Compounded semaglutide requires temperature-controlled shipping (cold packs or refrigerated courier), which can add 1 to 2 days compared to standard mail.

Is compounded semaglutide safe? Compounded semaglutide from a licensed 503A or 503B pharmacy that follows sterility testing protocols is generally safe, but it carries more risk than FDA-approved medications because it hasn't undergone the same review process. Quality varies by pharmacy. Ask for certificates of analysis and verify the pharmacy's inspection history.

Can I get compounded semaglutide in a pen? No. Compounding pharmacies cannot replicate the proprietary pen device used by Novo Nordisk. Compounded semaglutide is dispensed in vials and injected with standard insulin syringes.

Do telehealth platforms accept Medicare or Medicaid? Most telehealth platforms for compounded semaglutide are cash-pay only. Medicare and Medicaid do not typically cover compounded weight-loss medications. Check with the specific platform.

How do I know if a telehealth platform is legitimate? Verify the platform uses U.S.-licensed providers (check state medical board databases), contracts with licensed 503A or 503B pharmacies (verify via FDA or state pharmacy board), requires a provider consultation before prescribing, and discloses that compounded semaglutide is not FDA-approved.

Can I switch from Ozempic to compounded semaglutide? Yes. If you're currently on Ozempic and want to switch to compounded semaglutide (usually for cost reasons), continue your current dose. The active ingredient is the same. Inform your new provider of your current dose and any side effects. Most platforms allow seamless transitions.

Sources

1. FDA Drug Shortages Database. Semaglutide injection shortage status. Updated April 2026. Accessed April 2026.
2. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002.
3. FDA Docket FDA-2023-N-5899. Semaglutide drug shortage reconsideration. November 2023.
4. Pew Charitable Trusts. Compounding Pharmacy Oversight and Sterility Testing Compliance. 2023.
5. FDA Warning Letters. Unapproved and Misbranded Semaglutide Products. 2024-2025.
6. Federal Food, Drug, and Cosmetic Act. Section 503A and 503B. Pharmacy Compounding Regulations. Updated 2023.
7. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397:971-984.
8. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325:1414-1425.
9. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28:2083-2091.
10. FDA Outsourcing Facilities Database. 503B Registered Facilities. Accessed April 2026.
11. National Association of Boards of Pharmacy. State Pharmacy License Verification Tools. 2026.
12. Blonde L et al. American Association of Clinical Endocrinologists Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan. Endocrine Practice. 2022;28:923-1049.
13. Kushner RF et al. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity. 2020;28:1050-1061.
14. FDA Health Fraud Program. Reporting Illegal Online Pharmacies. Updated 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.